Prevalence and Predictors of Post-Discharge Antibiotic Use Following Mastectomy
Supporting Files
-
9 2017
-
File Language:
English
Details
-
Alternative Title:Infect Control Hosp Epidemiol
-
Personal Author:
-
Description:Objective
Surveys suggest prolonged administration of prophylactic antibiotics is common after mastectomy with reconstruction. We determined utilization, predictors, and outcomes of post-discharge prophylactic antibiotics after mastectomy ± immediate breast reconstruction.
Design
Retrospective cohort.
Patients
Commercially insured women aged 18–64 years coded for mastectomy from 1/2004–12/2011. Women with a preexisting wound complication or septicemia were excluded.
Methods
Predictors of prophylactic antibiotics within 5 days after discharge were identified in women with one year prior insurance enrollment; relative risks (RR) were calculated using generalized estimating equations.
Results
12,501 mastectomy procedures were identified, with immediate reconstruction in 7,912 (63.3%). Post-discharge prophylactic antibiotics were used in 4,439 (56.1%) procedures with and 1,053 (22.9%) without immediate reconstruction (p < .001). The most common antibiotics were cephalosporins (75.1%) and fluoroquinolones (11.1%). Independent predictors of post-discharge antibiotics were implant reconstruction (RR 2.41, 95% confidence interval [CI] 2.23, 2.60), autologous reconstruction (RR 2.17, 95% CI 1.93, 2.45), autologous reconstruction plus implant (RR 2.11, 95% CI 1.92, 2.31), hypertension (RR 1.05, 95% CI 1.00, 1.10), tobacco use (RR 1.07, 95% CI 1.01, 1.14), surgery at an academic hospital (RR 1.14, 95% CI 1.07, 1.21), and receipt of home health care (RR 1.11, 95% CI 1.04, 1.18). Post-discharge prophylactic antibiotics were not associated with SSI after mastectomy ± immediate reconstruction (both p > 0.05).
Conclusions
Prophylactic post-discharge antibiotics are common after mastectomy, with immediate reconstruction the strongest predictor. Stewardship efforts in this population to limit continuation of prophylactic antibiotics after discharge are needed to limit antimicrobial resistance.
-
Subjects:
-
Source:Infect Control Hosp Epidemiol. 38(9):1048-1054
-
Pubmed ID:28669356
-
Pubmed Central ID:PMC5645083
-
Document Type:
-
Funding:R24 HS019455/HS/AHRQ HHSUnited States/ ; U54 CK000609/CK/NCEZID CDC HHSUnited States/ ; P30 CA091842/CA/NCI NIH HHSUnited States/ ; UL1 TR000448/TR/NCATS NIH HHSUnited States/ ; UL1 TR002345/TR/NCATS NIH HHSUnited States/ ; U54 CK000162/CK/NCEZID CDC HHSUnited States/ ; R01 CA149614/CA/NCI NIH HHSUnited States/
-
Volume:38
-
Issue:9
-
Collection(s):
-
Main Document Checksum:urn:sha256:c15569e9cf029d312b1f5f4135cb661989181c290471ba2da219ab32249bd656
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access